History of fragility fracture is associated with cardiovascular mortality in hemodialysis patients: the Q-Cohort study

[1] Ginsberg C(2022)Diagnosis and management of osteoporosis in advanced kidney disease: a review Am J Kidney Dis 79 427-436

[2] Ix JH(2017)Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation Kidney Int 92 1343-1355

[3] Pimentel A(2021)European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D Nephrol Dial Transplant 36 42-59

[4] Urena-Torres P(2001)Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 938-942

[5] Zillikens MC(2015)High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis J Am Soc Nephrol 26 2534-2544

[6] Bover J(2009)Vascular calcifications, vertebral fractures and mortality in haemodialysis patients Nephrol Dial Transplant 24 239-246

[7] Cohen-Solal M(2017)Chronic kidney disease and fragility fracture Clin Exp Nephrol 21 46-52

[8] Evenepoel P(2012)Bone-vascular cross-talk J Nephrol 25 619-625

[9] Cunningham J(2016)Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease Kidney Int 90 77-89

[10] Ferrari S(2020)Bone mineral density and mortality in end-stage renal disease patients Clin Kidney J 13 307-321

[1] Ginsberg C(2022)Diagnosis and management of osteoporosis in advanced kidney disease: a review Am J Kidney Dis 79 427-436

[2] Ix JH(2017)Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation Kidney Int 92 1343-1355

[3] Pimentel A(2021)European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D Nephrol Dial Transplant 36 42-59

[4] Urena-Torres P(2001)Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 938-942

[5] Zillikens MC(2015)High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis J Am Soc Nephrol 26 2534-2544

[6] Bover J(2009)Vascular calcifications, vertebral fractures and mortality in haemodialysis patients Nephrol Dial Transplant 24 239-246

[7] Cohen-Solal M(2017)Chronic kidney disease and fragility fracture Clin Exp Nephrol 21 46-52

[8] Evenepoel P(2012)Bone-vascular cross-talk J Nephrol 25 619-625

[9] Cunningham J(2016)Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease Kidney Int 90 77-89

[10] Ferrari S(2020)Bone mineral density and mortality in end-stage renal disease patients Clin Kidney J 13 307-321